Get Free Sample link @ https://www.omrglobal.com/request-sample/biological-drugs-market
According to the Center for Disease Control and Prevention (CDC), 129 million or 51.8% of noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. Additionally, 24.6% (61 million) of adults had 1 chronic condition, and 27.2% (68 million) had equal or more than 2 chronic conditions. Furthermore, as per American Action Forum, the total cost of chronic disease in the US reaches $3.7 trillion each year which is almost 19.6% of the country’s gross domestic product (GDP). Hence, the rising chronic disease is driving the demand for biological drugs which in turn is driving the market growth.
A full report of Global Biological Drugs Market available @ https://www.omrglobal.com/industry-reports/biological-drugs-market
Market Coverage
.Market number available for – 2019-2026
.Base year- 2019
.Forecast period- 2020-2026
.Segment Covered- By Source, By Product Type, By Applications
.Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others

Global Biological Drugs Market Report by Segment
By Product
• Therapeutic Protein
• Monoclonal Antibody
• Vaccine
Global Biological Drugs Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/biological-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404